Abstract:Background: There is growing evidence of associations between the gut microbiota and anxiety disorders, where changes in gut microbiotas may affect brain function and behavior via the microbiota-gut-brain axis. However, population-level studies offering a higher level of evidence for causality are lacking. Our aim was to investigate the specific gut microbiota and associated metabolites that are closely related to anxiety disorders to provide mechanistic insights and novel management perspectives for anxiety disorders. Method: This study used summary-level data from publicly available Genome-Wide Association Studies (GWAS) for 119 bacterial genera and the phenotype "All anxiety disorders" to reveal the causal effects of gut microbiota on anxiety disorders and identify specific bacterial genera associated with anxiety disorders. A two-sample, bidirectional Mendelian randomization (MR) design was deployed, followed by comprehensive sensitivity analyses to validate the robustness of results. We further conducted multivariable MR (MVMR) analysis to investigate the potential impact of neurotransmitter-associated metabolites, bacteria-associated dietary patterns, drug use or alcohol consumption, and lifestyle factors such as smoking and physical activity on the observed associations. Results: Bidirectional MR analysis identified three bacterial genera causally related to anxiety disorders: the genus Eubacterium nodatum group and genus Ruminococcaceae UCG011 were protective, while the genus Ruminococcaceae UCG011 was associated with an increased risk of anxiety disorders. Further MVMR suggested that a metabolite-dependent mechanism, primarily driven by tryptophan, tyrosine, phenylalanine, glycine and cortisol, which is consistent with previous research findings, probably played a significant role in mediating the effects of these bacterial genera to anxiety disorders. Furthermore, modifying dietary pattern such as salt, sugar and processed meat intake, and adjusting smoking state and physical activity levels, appears to be the effective approaches for targeting specific gut microbiota to manage anxiety disorders. Conclusion: Our findings offer potential avenues for developing precise and effective management approaches for anxiety disorders by targeting specific gut microbiota and associated metabolites.

Gut microbiome and major depressive disorder: insights from two-sample Mendelian randomization

Causal relationships between gut microbiota and depression/anxiety disorders: A 2-sample Mendelian randomization study.

Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study

Causal effects of gut microbiota on the risk of bipolar disorder: a Mendelian randomization study

Gut microbiota and postpartum depression: a Mendelian randomization study

Gut microbiome and schizophrenia: insights from two-sample Mendelian randomization

Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia

The causal association between gut microbiota and postpartum depression: a two-sample Mendelian randomization study

Dissecting the Association Between Gut Microbiota, Body Mass Index and Specific Depressive Symptoms: a Mediation Mendelian Randomisation Study

Association between gut microbiota and postpartum depression: A bidirectional Mendelian randomization study

Altered gut bacterial-fungal interkingdom networks in children and adolescents with depression

Depression and risk of gastrointestinal disorders: a comprehensive two-sample Mendelian randomization study of European ancestry

Differential Gut Microbiota Compositions Related With the Severity of Major Depressive Disorder

Association between gut microbiota and anxiety disorders: a bidirectional two-sample mendelian randomization study

Relationships between the gut microbiome and brain functional alterations in first-episode, drug-naïve patients with major depressive disorder

Improving precision management of anxiety disorders: a Mendelian randomization study targeting specific gut microbiota and associated metabolites

Association between major depressive disorder and gut microbiota dysbiosis

Possible Association of Firmicutes in the Gut Microbiota of Patients with Major Depressive Disorder.

Exploration of the relationship between gut microbiota and fecal microRNAs in patients with major depressive disorder

The impact of depression-mediated gut microbiota composition on Irritable Bowel Syndrome: A Mendelian study

Anorexia nervosa and bulimia nervosa: a Mendelian randomization study of gut microbiota